国内吸入剂“销冠”,卖了484亿元

药智网
Feb 02

药智数据显示,2016年至2025年前三季度,国内公立医疗机构吸入制剂销售额排名中,吸入用布地奈德混悬液(按照品种计)的累计销售额达483.73亿元,稳坐近十年吸入制剂领域的“销售冠军”宝座。值得关注的是,在此统计周期内,该品种十年蝉联年度销售额榜首,始终保持着领跑地位。注:本次统计的吸入制剂范畴,涵盖中国市场获批的全部创新药与仿制药;统计口径以品种为单位,而非品牌维度。01十年霸权根据药智数据,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10